BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31642987)

  • 1. Risk stratification system for groups with a low, intermediate, and high risk of subsequent distant metastasis and death following isolated locoregional recurrence of breast cancer.
    Lee YJ; Park H; Kang CM; Gwark SC; Lee SB; Kim J; Chung IY; Ko BS; Kim HJ; Kim SB; Ahn SD; Gong G; Son BH; Ahn SH; Lee JW
    Breast Cancer Res Treat; 2020 Jan; 179(2):315-324. PubMed ID: 31642987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcome of isolated locoregional recurrence in patients with breast cancer according to their primary local treatment.
    Shenouda MN; Sadek BT; Goldberg SI; Keruakous AR; Croft BJ; Abi Raad RF; Taghian AG
    Clin Breast Cancer; 2014 Jun; 14(3):198-204. PubMed ID: 24485702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prediction model for distant metastasis after isolated locoregional recurrence of breast cancer.
    Murata T; Yoshida M; Shiino S; Ogawa A; Watase C; Satomi K; Jimbo K; Maeshima A; Iwamoto E; Takayama S; Suto A
    Breast Cancer Res Treat; 2023 May; 199(1):57-66. PubMed ID: 36869991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poor Prognosis After Second Locoregional Recurrences in the CALOR Trial.
    Wapnir IL; Gelber S; Anderson SJ; Mamounas EP; Robidoux A; Martín M; Nortier JW; Geyer CE; Paterson AH; Láng I; Price KN; Coates AS; Gelber RD; Rastogi P; Regan MM; Wolmark N; Aebi S;
    Ann Surg Oncol; 2017 Feb; 24(2):398-406. PubMed ID: 27663567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of isolated locoregional recurrence of breast cancer: results of four prospective studies.
    Schmoor C; Sauerbrei W; Bastert G; Schumacher M
    J Clin Oncol; 2000 Apr; 18(8):1696-708. PubMed ID: 10764430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological Features and Prognostic Factors Affecting Survival Outcomes in Isolated Locoregional Recurrence of Breast Cancer: Single-Institutional Series.
    Lee MY; Chang WJ; Kim HS; Lee JY; Lim SH; Lee JE; Kim SW; Nam SJ; Ahn JS; Im YH; Park YH
    PLoS One; 2016; 11(9):e0163254. PubMed ID: 27648567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between the 21-gene recurrence score and isolated locoregional recurrence in stage I-II, hormone receptor-positive breast cancer.
    Yang DD; Buscariollo DL; Cronin AM; Weng S; Hughes ME; Bleicher RJ; Cohen AL; Javid SH; Edge SB; Moy B; Niland JC; Wolff AC; Hassett MJ; Punglia RS
    Radiat Oncol; 2020 Aug; 15(1):198. PubMed ID: 32799886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Chemotherapy for ER-Negative and ER-Positive Isolated Locoregional Recurrence of Breast Cancer: Final Analysis of the CALOR Trial.
    Wapnir IL; Price KN; Anderson SJ; Robidoux A; Martín M; Nortier JWR; Paterson AHG; Rimawi MF; Láng I; Baena-Cañada JM; Thürlimann B; Mamounas EP; Geyer CE; Gelber S; Coates AS; Gelber RD; Rastogi P; Regan MM; Wolmark N; Aebi S; ; ;
    J Clin Oncol; 2018 Apr; 36(11):1073-1079. PubMed ID: 29443653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of PAM50 and risk of recurrence score in patients with early-stage breast cancer with long-term follow-up.
    Ohnstad HO; Borgen E; Falk RS; Lien TG; Aaserud M; Sveli MAT; Kyte JA; Kristensen VN; Geitvik GA; Schlichting E; Wist EA; Sørlie T; Russnes HG; Naume B
    Breast Cancer Res; 2017 Nov; 19(1):120. PubMed ID: 29137653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.
    Touboul E; Buffat L; Belkacémi Y; Lefranc JP; Uzan S; Lhuillier P; Faivre C; Huart J; Lotz JP; Antoine M; Pène F; Blondon J; Izrael V; Laugier A; Schlienger M; Housset M
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):25-38. PubMed ID: 9989511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant therapy after excision and radiation of isolated postmastectomy locoregional breast cancer recurrence: definitive results of a phase III randomized trial (SAKK 23/82) comparing tamoxifen with observation.
    Waeber M; Castiglione-Gertsch M; Dietrich D; Thürlimann B; Goldhirsch A; Brunner KW; Borner MM;
    Ann Oncol; 2003 Aug; 14(8):1215-21. PubMed ID: 12881382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy of isolated locoregional recurrent carcinoma of the breast.
    Gabriel L; Schmidt M; Juhasz-Böss S; Melchior P; von Heesen A; Schmidt G; Kranzhöfer N; Solomayer EF; Juhasz-Böss I; Breitbach GP
    Arch Gynecol Obstet; 2019 Aug; 300(2):365-376. PubMed ID: 31222400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical validation of an immunohistochemistry-based CanAssist-Breast test for distant recurrence prediction in hormone receptor-positive breast cancer patients.
    Bakre MM; Ramkumar C; Attuluri AK; Basavaraj C; Prakash C; Buturovic L; Madhav L; Naidu N; R P; Somashekhar SP; Gupta S; Doval DC; Pegram MD
    Cancer Med; 2019 Apr; 8(4):1755-1764. PubMed ID: 30848103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying Long-Term Survival Candidates among Patients with Isolated Locoregionally Recurrent Breast Cancer: Implications of the Use of Systemic Chemotherapy.
    Kim BH; Shin KH; Chie EK; Kim JH; Kim K; Hwang KT; Kim J; Choi IS; Park JH; Kim S
    J Breast Cancer; 2020 Jun; 23(3):279-290. PubMed ID: 32595990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 21-Gene recurrence score and locoregional recurrence in lymph node-negative, estrogen receptor-positive breast cancer.
    Turashvili G; Chou JF; Brogi E; Morrow M; Dickler M; Norton L; Hudis C; Wen HY
    Breast Cancer Res Treat; 2017 Nov; 166(1):69-76. PubMed ID: 28702894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival and pattern of failure following locoregional recurrence of breast cancer.
    Kamby C; Sengeløv L
    Clin Oncol (R Coll Radiol); 1999; 11(3):156-63. PubMed ID: 10465468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postmastectomy radiotherapy improves disease-free survival of high risk of locoregional recurrence breast cancer patients with T1-2 and 1 to 3 positive nodes.
    He ZY; Wu SG; Zhou J; Li FY; Lin Q; Lin HX; Sun JY
    PLoS One; 2015; 10(3):e0119105. PubMed ID: 25781605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Strategies for the Management of Locoregional Breast Cancer Recurrence.
    Wapnir IL; Khan A
    Oncology (Williston Park); 2019 Jan; 33(1):19-25. PubMed ID: 30731014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-state model for studying an intermediate event using time-dependent covariates: application to breast cancer.
    Meier-Hirmer C; Schumacher M
    BMC Med Res Methodol; 2013 Jun; 13():80. PubMed ID: 23786493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive locoregional treatment and systemic therapy for postmastectomy isolated locoregional recurrence.
    Kuo SH; Huang CS; Kuo WH; Cheng AL; Chang KJ; Chia-Hsien Cheng J
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1456-64. PubMed ID: 18692329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.